# A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease

> **NCT00162370** · PHASE4 · COMPLETED · sponsor: **Lantheus Medical Imaging** · enrollment: 400 (actual)

## Conditions studied

- Coronary Artery Disease
- Heart Disease

## Interventions

- **DRUG:** Perflutren Lipid Microsphere Injectable Suspension

## Key facts

- **NCT ID:** NCT00162370
- **Lead sponsor:** Lantheus Medical Imaging
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2012-09
- **Final completion:** 2012-10
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2021-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00162370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00162370, "A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00162370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*